Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.004 | 0.7722 | 0.6887 | |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0039 | 0.7486 | 1 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0024 | 0.3971 | 0.5305 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0026 | 0.4383 | 0.5834 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0009 | 0.0267 | 0.0356 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.8648 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0026 | 0.4383 | 0.5834 |
Mycobacterium ulcerans | polyketide synthase | 0.0028 | 0.4773 | 0.6357 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.1625 | 0.0823 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0026 | 0.4383 | 0.4383 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0028 | 0.4773 | 1 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0018 | 0.2576 | 0.3708 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0008 | 0.0081 | 0.0056 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0026 | 0.4383 | 0.581 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0028 | 0.4773 | 0.6376 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0026 | 0.4383 | 0.5856 |
Mycobacterium ulcerans | thioesterase | 0.0022 | 0.3337 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0011 | 0.0647 | 0.0864 |
Giardia lamblia | Methyltransferase like 2 | 0.0008 | 0 | 0.5 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0028 | 0.4773 | 0.6337 |
Brugia malayi | AMP-binding enzyme family protein | 0.0008 | 0.0039 | 0.0039 |
Onchocerca volvulus | 0.0045 | 0.9028 | 0.9285 | |
Mycobacterium ulcerans | thioesterase TesA | 0.0022 | 0.3337 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0021 | 0.324 | 0.4329 |
Leishmania major | hypothetical protein, conserved | 0.0008 | 0 | 0.5 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0028 | 0.4773 | 0.6337 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0026 | 0.4383 | 0.5856 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0026 | 0.4383 | 0.5856 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0028 | 0.4773 | 0.6337 |
Loa Loa (eye worm) | fatty acid synthase | 0.0026 | 0.43 | 0.4318 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0028 | 0.4773 | 0.6357 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0025 | 0.4191 | 0.5599 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0026 | 0.4383 | 0.5834 |
Schistosoma mansoni | methyltransferase-related | 0.0008 | 0 | 0.5 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0017 | 0.218 | 0.2574 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0026 | 0.4383 | 0.581 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0039 | 0.7486 | 1 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0028 | 0.4773 | 0.6376 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0025 | 0.4191 | 0.5599 |
Mycobacterium tuberculosis | Polyketide synthetase MbtD (polyketide synthase) | 0.0008 | 0.0039 | 0.0052 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0028 | 0.4773 | 0.6376 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0039 | 0.7486 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0021 | 0.3157 | 0.4188 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0039 | 0.7486 | 1 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0017 | 0.2258 | 0.2981 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0019 | 0.2616 | 0.3495 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0022 | 0.3337 | 0.4459 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0024 | 0.3971 | 0.3889 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0022 | 0.3337 | 0.4398 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0028 | 0.4773 | 0.6357 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0026 | 0.4383 | 0.5834 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0047 | 0.9418 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0021 | 0.3157 | 0.4188 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0015 | 0.1676 | 0.224 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0017 | 0.2258 | 0.2981 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0017 | 0.2258 | 0.2941 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0008 | 0.0081 | 0.0108 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.3971 | 0.3971 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0021 | 0.3157 | 0.4155 |
Mycobacterium ulcerans | polyketide synthase | 0.0026 | 0.4383 | 0.5834 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC99 (functional) | = 3.75 uM | Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by broth microdilution method | ChEMBL. | 24333580 |
MIC99 (functional) | > 120.02 uM | Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 3 weeks by microbroth dilution method | ChEMBL. | 24333580 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.